
Jeanette M. Lieb
Examiner (ID: 4527, Phone: (571)270-3490 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 1052 |
| Issued Applications | 767 |
| Pending Applications | 108 |
| Abandoned Applications | 207 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19256875
[patent_doc_number] => 12016904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF
[patent_app_type] => utility
[patent_app_number] => 18/062534
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 63330
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062534
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062534 | Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF | Dec 5, 2022 | Issued |
Array
(
[id] => 18829655
[patent_doc_number] => 20230398179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => APPLICATION OF SKELETAL MUSCLE SECRETED FACTOR THBS4 IN PREPARATION OF DRUG FOR IMPROVING SYSTEMIC GLUCOSE AND LIPID METABOLISM
[patent_app_type] => utility
[patent_app_number] => 18/062028
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062028
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062028 | Application of skeletal muscle secreted factor THBS4 in preparation of drug for improving systemic glucose and lipid metabolism | Dec 5, 2022 | Issued |
Array
(
[id] => 18612336
[patent_doc_number] => 20230279068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
[patent_app_type] => utility
[patent_app_number] => 18/074275
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18074275
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/074275 | Targeting anabolic drugs for accelerated fracture repair | Dec 1, 2022 | Issued |
Array
(
[id] => 19667578
[patent_doc_number] => 12180306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Anti-allergic peptide and use thereof for immune regulation and anti-allergy
[patent_app_type] => utility
[patent_app_number] => 18/061238
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 6619
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061238 | Anti-allergic peptide and use thereof for immune regulation and anti-allergy | Dec 1, 2022 | Issued |
Array
(
[id] => 19274435
[patent_doc_number] => 12024546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Peptides and anti-cancer compositions including thereof
[patent_app_type] => utility
[patent_app_number] => 18/070125
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 96
[patent_no_of_words] => 14545
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070125
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070125 | Peptides and anti-cancer compositions including thereof | Nov 27, 2022 | Issued |
Array
(
[id] => 19187786
[patent_doc_number] => 20240166699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => METHOD FOR PREVENTING HUMAN CELL INFECTION BY HERPESVIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/058516
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058516
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/058516 | Method for preventing human cell infection by herpesviruses | Nov 22, 2022 | Issued |
Array
(
[id] => 18451625
[patent_doc_number] => 20230192904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/057127
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057127
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057127 | Bifunctional chimeric molecules for labeling of kinases with target binding moieties and methods of use thereof | Nov 17, 2022 | Issued |
Array
(
[id] => 19410591
[patent_doc_number] => 12076383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
[patent_app_type] => utility
[patent_app_number] => 18/056843
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 26924
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056843 | Compositions and methods for inducing humoral and cellular immunities against tumors and cancer | Nov 17, 2022 | Issued |
Array
(
[id] => 18675108
[patent_doc_number] => 20230312686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/985012
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985012 | Glypican-3-binding fibronectin based scaffold molecules | Nov 9, 2022 | Issued |
Array
(
[id] => 18283964
[patent_doc_number] => 20230099436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD FOR PREPARING NATURAL BIOACTIVE PEPTIDE TUBULYSIN U
[patent_app_type] => utility
[patent_app_number] => 17/984642
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 492
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984642
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984642 | Method for preparing natural bioactive peptide Tubulysin U | Nov 9, 2022 | Issued |
Array
(
[id] => 20157000
[patent_doc_number] => 12383598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Method for treating gingivitis and gingival atrophy and repairing oral mucosa
[patent_app_type] => utility
[patent_app_number] => 18/048025
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 0
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048025
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048025 | Method for treating gingivitis and gingival atrophy and repairing oral mucosa | Oct 18, 2022 | Issued |
Array
(
[id] => 18449589
[patent_doc_number] => 20230190865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => VIP Antagonists and Uses in Treating Cancer
[patent_app_type] => utility
[patent_app_number] => 18/047135
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047135
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047135 | VIP Antagonists and Uses in Treating Cancer | Oct 16, 2022 | Pending |
Array
(
[id] => 18322507
[patent_doc_number] => 20230120635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => Peptides and Fragments for Treating Diabetes and Associated Metabolic Diseases
[patent_app_type] => utility
[patent_app_number] => 17/963700
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/963700 | Peptides and fragments for treating diabetes and associated metabolic diseases | Oct 10, 2022 | Issued |
Array
(
[id] => 18310051
[patent_doc_number] => 20230113951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => SYSTEMS AND METHODS OF TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/964023
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/964023 | Systems and methods of treating prostate cancer | Oct 10, 2022 | Issued |
Array
(
[id] => 18349758
[patent_doc_number] => 20230137869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => METHOD OF SUGAR-GUIDED MODIFYING GLYCOSYLATED POLYPEPTIDE AND APPLICATION OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/954929
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17954929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/954929 | Method of sugar-guided modifying glycosylated polypeptide and application of the same | Sep 27, 2022 | Issued |
Array
(
[id] => 18626587
[patent_doc_number] => 20230285378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => Anti-Viral Compounds
[patent_app_type] => utility
[patent_app_number] => 17/941090
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941090 | Anti-Viral Compounds | Sep 8, 2022 | Abandoned |
Array
(
[id] => 18451514
[patent_doc_number] => 20230192792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/821669
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821669
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821669 | ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE | Aug 22, 2022 | Abandoned |
Array
(
[id] => 18284775
[patent_doc_number] => 20230100247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => TAXOL CONJUGATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/890906
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890906 | Taxol conjugate compounds, pharmaceutical compositions comprising the same, and methods for their use | Aug 17, 2022 | Issued |
Array
(
[id] => 19498628
[patent_doc_number] => 20240337646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING MELANOMA
[patent_app_type] => utility
[patent_app_number] => 18/293692
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293692
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/293692 | COMPOSITIONS AND METHODS FOR TREATING MELANOMA | Jul 28, 2022 | Pending |
Array
(
[id] => 19105833
[patent_doc_number] => 11958914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => CAR-T cells targeting glioma stem cells for the treatment of glioblastoma multiforme
[patent_app_type] => utility
[patent_app_number] => 17/811945
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 37726
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811945
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811945 | CAR-T cells targeting glioma stem cells for the treatment of glioblastoma multiforme | Jul 11, 2022 | Issued |